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IN a series of earlier investigations it was shown that two transplantable
mammary adenocaremomata, one which arose in a mouse of the C3H strain and
the other iin a mouse of the DBA strain, differed significantly in their biological
and physiological properties, as evidenced by their rate of growth, metabohe
activity, and radiosensitivity (Goldfeder, 1947 ; Goldfeder and Cameron, 1948
Goldfeder, 1950a, 1950b, 1951). A significant number of mice of both C3H and
DBA strains, in which either previously irradiated tumour grafts failed to pro-
duce tumours or established, actively growing tumours regressed foHowing
irradiation, became resistant to viabl6grafts oftherespective tumours (Goldfeder,
1950a). However, it was not known whether these two tumours had been
seriaRytransplanted in micegenetically identical with those in which the tumours
originaRy developed, as the mice were obtained from various laboratories (Gold-
feder., 1950a). The mice used for transplantation undoubtedly came from
different sublines of these two strains. Therefore, additional experiments were
carried, out in an attempt to elucidate the foRowing questions:
1. What is the underlying factor or factors responsible for the difference in
the radiosensitivity of mammary tumours?
2. Is it possible to induce an immune state inhomozygous mice to auto'genous
tumours by inoculation of these tumours attenuated by irradiation?
3. Does the regression of a well-developed transplanted tumour foRowing irradiation in vivo render the animal resistant to the development ofspontaneous
tumours?
This study was made possible by the use of the irradiation technique (Gold- feder, 1950a) which facihtates the exposure of the tumour and protects the rest
of the body of the animal from secondary scattered radiation, thus permitting the treated animals to Eve their life span. Previous work on the irradiation of
tumours has been summarized by the writer (1945a). There is no doubt that
results obtained with tumoursheterogenous to the animal bosts-that is, tumours
which have a different genetic constitution from that ofthe host, are not compar- able with those obtained with tumours autogenous to the animal hosts-that is
with tumours having the same genetic constitution as that of the host, or with, those in patients suffering from cancer. As will be seen, the results obtained in
animal experiments, using hosts and tumours of the same genetic derivation are
comparable with observations frequently noted in human cancerpatients.
* Apreliminary report of this investigation was presented at the Annual Meeting of the American
Association for Cancer Research, April, 1952, (Goldfeder, 1952).RADIOSENSITIVITY AND
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MATERIAL AND METHODS
C3H mice for breeding purposes were supplied by Dr. J. J. Bittner with the
following information :
" The mice we have sent you have been ofpure lines tested
to be homozv-aous ; they bear the milkagent and have an incidence ofspontaneous ' qz.l
tumours of over 90 per cent." Severalpairs ofDBA breeders were obtained from
Dr. T. C. Hauschka, of the Cancer Institute in Philadelphia, who stated:
" The
Lankenau Hospital Research Institute originally obtained DBA mice from the
Jackson B. MemorialLaboratory on Julv 5, 1933, andthey weredesignated at that
time as inbred strain 'D'. These mice have been inbred since: they behave
immunologicaRy like DBA/212, and have an incidence of over 85 pe'r cent of
spontaneous mammary tumours among breeding females. Mean tumour age
8 nionths ; range from 6-12. months; based on a total of 62 breedinor females."
Mice of both the C3H and DBA lines were bred by brother to sister matings
in the writer's laboratory. Purina laboratory chow and water ad libitum consti-
tuted the basic diet. Ma-ture mice also received lettuce or carrots twice weekly
and sunflower seeds occasionally; the nursing mothers received bread soaked in
milk. Spontaneous tumours developed in 7-12-month-old females of both C3H
and DBA strains.
A spontaneous mammary tumour of a 9-month-old C3H female mouse was
excised underaseptic conditions. Theedges of the tumour we-re cut with asharp
scalpel into pieces about 2 mm. in diameter and transplanted into 8 6-week-old
mice. Palpable tumours appeared in all 8 mice within 14 to 16 davs following
transplantation.
Several cross-sections of the primary tumour were fixed in Zenker's fluid and
stained with Harris haematoxylin and eosin. The bistological appearance of
the tumour was that of an adenocarcinoma Type B, according to the classification
of Dunn (1945) (Fig. 1). This tumour has been carried in serial transplants in
C3H mice for the past 4 vears. There has been 100 per cent of
" takes
" and
no instance of spontaneous regression. A tumour of about 5 mm. in diameter
usuaUy develops from an implant within a period of 12 to 14 days, and grows
progressively.
Aspontaneous mammary tumour of an I1-month-oldfemale mouse ofthe DBA
strain was excised asepticaRy. This tumour was :firmer in consistency than that
removed from the C3H mouse described. Fragments of about 2 mm. dissected
from the edges of the tumour were implanted subcutaneously into 10 DBA mice
(8 males and 2 females). Tumours of about 5 mm. in diameter appeared in all
grafted niice within 16 to 18 days.
Cross-sections of the original tumour were fixed and stained by the same pro-
cedure as that used for the C3H tumour. This tumour accorcling to Dunn (1945)
re-presented an adenocarcinoma Type A (Fig. 2). It has been carried in serial
transplants in mice of the DBA strain for more than 4 years. Its rate ofgrowth
is rather constant. Implants usually develop into tumours of measurable size
within 12 to 16 days.
The spontaneous mammary tumours arising in mice of both strains (C3H and
DBA) are of different types: Haemorrhagic, cystic, or sohd, and varying in their
degree of differentiation. Individual mammary tumours, not only in different
mice of the same strain, but multiple tumours in the same mouse, may vary in
their biological characteristics, as show-n by Strong and Little (1920). Since the322 ANNA GOLDFEDER
above-mentioned properties plav a ro'le in the radiosensitivity of tumours, the
tumo'urs usedinthepresentexperiments arethereforespecificallydesignatedC3HB
and DBAH.
The investiuation on the radiosensitivity of these tumours started after the
eighth serial passage of both tumours.
The procedure of irradiation of tumour grafts in vitro was as follows : The
edges of the ti-imour were cut into pieces of about 2 cm. in diameter which were
then divided into two parts. One part was used for implantation into control
mice, while the other was exposed to X-radiation. The tumour pieces used for
irradiation were spread on a No. 1 round coverslip
7 inch in diameter, wbich had
been previously attached by a drop of sterile water to a mica sheet and covered
with a Maximow depression slide, in the concavity ofwl-lich moist filter paper had
been placed to maintain the water content of the tissue. The tissue was exposed
at 12-5 cm. target-tissue distance from an oil-cooled pulsating potential Coolidge
tube. The radiation factors were: 200 kV) 20 mA, 0-5 mm. Cuplus 1-0 mm. Al
filtration ; HVL of 1-1 mm. Cu. The dose rate was 602 r/min. measured in air
(± 5 per cent). The absorption of radiation by the cover glass, mica sheet and
Maximow slide was about IO per cent, which was taken into consideration in calcu-
lating the X-ray dose delivered to the tumour tissue. Immediately after irradia-
tion the tumour fragments were implanted into about 2-3-month-old mice, most
ofwhich were litter mates. In two additional experiments the mice wereinjected
intradermally with aliquots of irradiated. tumour cells, suspended in physiological
saline. This was donebecause, according to observations madeby several investi-
gators, the intradermal route of immunization appears to produce more effective
andlasting results (Besredka,Magat, Laval andBesnard, 1936 ; Kolmar andTuft,
1941). For the latter experiments the tumour fragments following irradiation
were cut with sharp curved scissors until an almost homogeneous mass was
obtained. A dense cellsuspension was made in sterile 0-85 per cent saline solution
(about 10,000cells/c. nim.). This cellsuspension wasinjectedintracutaneously in
0
-05 c.c. dosesbymea'ns of a tuberculiin syringe and .25 gauge needle in two or three
sites of the abdominal wall of each mouse.
The latent period and the number of
" takes
" produced by tumciur grafts
irradiated in vitro served as criteria ofthe effect of agiven dose of X-radiation.
The procedure ofirradiation of the estabhshed tumours in v&'vo was as follows
Actively growing tumours ranging in size from 1-0 to 1-5 cm. in diameter were
exposed to filtered X-radiation while the rest ofthe animal orgamsm was shielded
bv a lead chamber (Goldfeder, 1950a). During theearlyexperiments the tumours
were irradiated in vivo under the same physical conditions as the tumour grafts
in vitro. During the later experiments, the following physical factors were
employed: The radiation was generated by a Westinghouse
" Quadrocondex
"
Constant potential unit at 200 kV, 15 mA ; the incident beam was filtered by
0-5 mm. Cuplus I
-0 mm. Al ; HVLequalled I
-0 mm. Cu ; FSD, 20.0 cm. ; fieldsize,
12 cm. in diameter. The dose rate measuredin airbv athimbleionization chamber
during the coiirse of the investigations varied from 395 r/min. to 402 r/min.
(± 5 per cent). Special measurements were made with and without the lead
shield, the ionizatioil chamber being placed in the same position. The measure-
ments indicated no significant scattering from the lead shield. Since the tumours
were relatively much smaller than the field size they were exposed to apractically
even distribution of radiation. Because ofthe sizes ofthe tumour (1-0 to 1-5 cm.RADIOSENSITIVITY AND
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in diameter) and HVL (1-0 mm. Cu), the back-scatter amounted to 5 per cent.
TheX-ray doses wereapphed to the tumours in asingle exposure. Measurements
ofthe tumours (length, width, andthickness) withcalipers were madeeverysecond
day or twice weekly. Complete regression of the irradiated tumours and the
survival time of the hosts 4 nionths thereafter without the appearance of new
growth, served as criteria for evaluation ofthe response ofthe tumours to agi'ven
dose offiltered X-radiation apphed in vivo. In addition, histological studies were
made ofsections taken from someprimary irradiated tumours and fromsecondary
tumoiirs which developed within 2 to 3 weeksfollowing irradiation ofthe primary
tumour either in the inguinal or axillary regions or oii the edges of the exposed
areas.
To determine the minimum X-ray dose producing complete regression of the
tumour, preliminary experiments on a smafl number of mice were carried out
and followed by irradiation of a larger number of tumours for better statistical
evaluation.
RESULTS.
A. Observations on C3HBTransplantableMammary Tumour.
The results obtained onimplantation ofthe irradiated C3HBtumour-grafts a-re
recorded in Table I are presented graphically in Fig. 3. The first'retardation of
tumour growth, as indicated by a slight increase in the latent period of tumour
appearance, was prodiiced by a dose of 2000 r. The increase of the X-ray dose
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FIG. 3.-Typical curves showing the percentage of tumour
" takes
" (C3HB and DBAH)
after various doses of radiation.324 ANNA GOLDFEDER
produced an increase in the latentperiod and a decrease in the number of
" takes."
A sudden drop of "takes
" occurred after a dose of 4000 r. Only 4 per cent of
the implants produced, tumours after exposure to 5400 r. No tumours were
produced by implants exposed to a dose of 5500 r.
In Experimerit No. II, an implant irradiated with 5000 r developed a tumour
after a latent period of 117 days. In this, as weR as in other similar instances,
the question arises whether the tumour cells had been attenuated by X-radiation
to such an extent that they remained dormant for this comparatively long'time,
or whether only a few ceRs had escapedinjury andtook, therefore, a muchlonger
time to develop a palpable tumour. This question cannot be answered with any
certainty. It is certain, however, that the tumour grew on the site of grafting
and that the rate of growth and the histologic'al pattem were similar to those
of a tumour developed by a non-irradiated implant.
In no instance did a tumour, developed by an irradiated implant, regress
spontaneously, contrary to observationsfrequentlymadewhenthe tumoiirimplant
and the host are not of the same genetic origin.
Searchfor induced re8i8tance
The mice in which the irradiated tumour grafts failed to produce tumours
(Experiments 7-14, Table I) were reimplanted with fresh, viable tumour grafts.
Due to the long latent period, the second implantation into mice of this series
was performed 3 to 4 months after the implantation of the irradiated tumour
grafts. The re'sults were clear cut : theimplanted viablegraftsproduced tumours
in the hosts after a latent period of 10 to 16 days and the tumours grew steadily
hke those of the control mice. Because of the time lapse between the first and
seconds graftings, further experiments were set up in an attempt to detect the
possible existence of an early
"immunity
" of short duration, as follows :
(1) Tumour fragments which had been irradiated with 5-300 r were implanted
into 30 C3H mice (20 males and 10 females).
(2) Tumourfragments irradiated with 5400 r wereimplanted into 30 C3H rnice
(25 males and 5 females).
(3) Tumour fragments irradiated with 5500 r were implanted into 28 mice
(20 males and 8 females)
EXPLANATION OF PLATES.
FIG. I.-Primarymammary tuznourwhich arose in a C3H mouse ofthehigh cancer line (Bittner line) and designated C3HB. Sheets and bands of tumour cells closelypacked. Some blood
vessels, mitoses and necrotic areas are also seen. Mammary adenocarcinomaType B, H and
E. x 230.
FIG. 2.--:-Primary mammary tumour which arose in a DBA mouse of a high cancer line and
designated DBAH. Acinar structures uniforinly distributed in the parenchyma and
separated by delicate stroma. Mammary adenocarcinorna Type A. H. and E. x 230.
FIG. 4.-Section of C3HB tumour removed 22 days following irradiation with 6000 r in vivo.
Sheets and bands of tumour cells are seen' among which are mitotic figures, particularly in
the areas near the blood vessel. Necrotic areas are also seen, but there is no fibrosis. H. and
E. x 230.
FIG. 5.-Section of DBAH tumour removed 22 days following irradiation with 6000 r in vivo.
Diffused fibrosis overgrowing the acinar structures can be seen. This is in contrast to
Fig. 4. H. and E. x 260.
FIG. 6.-DBA mice in which the DBAH tumour regressed following irradiation with 10,000 r
in vivo. Picture taken 181 months after treatment.BRITISH J01URNAL OF CANCER. Vol. VIII, No. 2.
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(4) Fifteen C3H male mice were injected intradermally with tumour cells
previously irradiated with 5400 r.
These doses ofirradiation were used because, as shown in Table 1, they consti-
tuted the attenuating dose*, and also because an overdose of radiation might
destroy the immunizing ability of the tumour grafts (Wedd, Morson and Russ,
1914 ; Goldfeder, 1942).
TABLE L-Results of Irradiation of C3HB Tumour Graft-s in vitro.
Number
of rnice
implanted.
20
20
25
25
25
25
25
25
28
22
28
24
25
25
Time of tumour
appearance
(days).
12-16
13-18
14-19
16-23
16-31
23-31
22-38
24-58
27-79
28-84
28-117
28-73
68
Number of
mice with
tumours.
20
20
25
25
25
25
23
19
16
10
8
3
1
0
Experixnent
number.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
Dose (r).
500
1000
1500
2000
2500
3000
3500
4000
4500
4700
5000
5300
5400
5500
" Takes
" (%)
100.0
100.0
100.0
100.0
100.0
100-0
92-0
76- 0
57
- 1
45-5
28- 6
12
- 5
4-0
0
None of the mice of the four series ofexperiments developed tumours within
2 weeks. They were tllen implanted with fresh, viable tumour grafts on the side
opposite to that of the previous implantation. Ten mice in each series were
grafted on both sides (left and right), in order to detect whether 'a local resistance
was induced by the irradiated tumour fragments previously grafted on the right side. Table 11 gives a summary of the results. It can be noted that the fresh,
viable tumour grafts produced palpable tumours in all mice used in the four
experiments, foRowing a latent period of 6 to 18 days. All the tumours grew progressiveky.
TABLEII.-Results ofRe-implantation of Viable Tumour Tissue into C3H Mice
in ttlhich Irradiated Tumour Implants Failed to Grow.
Number Latent
of Number of
" Takes
" period " Takes." onre-iinplantation. (days).
0 30 10-16
0 30 10-16
9 - 28 8-16
0 - 15 6-18
Number of Number
experiment. ofmice.
I 30
2 30
3 28
4 15
Dose
(r).
5300
5400
5500
5400
Remarks.
20malesand IO females -
25 males and 5 females.
20 males and 8 females.
All 15 mice were males.
They were injectecl
intradermaRy with
irradiated tumour
cells, but re-inocu-
lated by the use of
the trocar technique
with viable tumour
fragments.
* Definition of "attenuating" dose: A dose of irradiation which, when applied to tumour
fragments in vitro, prevents their growth in vivo (after transplantation into the mice) but does not
prevent their proliferation in vitro (in tissue culture) (Goldfeder, 1941, 1942).
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Results obtained uith C3HB transplantable, mamniary tumour8 treated in vivo.
A total of 189 C3H mice (148 males and 41 females) bearing the C3HB trans-
planted tumour were used in these experiments, and the results are recorded in
Table III. Doses of4000, 5000, and 6000 rproduced noregression ofthe tumours.
Retardation ofgrowth and decrease in size ofthe majority ofthe treated tumours
was noted within 10 days after irradiation, but later the tumours started to in-
crease in size andthey continued to grow. Aficroseopic examination of tumours
removed 22 days after exposure to 6000 r showed mitotic figures (Fig. 4). All
tumours, which had been treated witb 7000, 8000, and 10,000 r respectively,
decreased considerably in size within 10 to 14 days after exposure. However,
only 20 per cent of the tumours treated with 7000 r, approximately 49 per cent
ofthe tumours treated with 8000 r, and about 77 per cent of the tumours treated
with 10,000 r regressed after the treatment. A dose of 12,000 r completely
destroyed all the treated tumours. Sections of the tumours removed within
10 to 12 days after irradiation showedonly necrotic tissue. It appears, therefore,
that a dose within the range of I1,000 r to 12,000 r is lethal for the C3HB tumour
of 1-0 to 1-5 cni. in diameter when grow-n in vivo. This dose iB about twice aslarge
as that necessary for attenuation of the tumour grafts, prior to implantation
(Table 1). The irradiated tumours which resumed their growth after initial
decrease in size, grew steadily and in no instance did a tumour regress once it
began to grow again.
OccasionaRy secondary tumours developed in the treated mice either in the
inguinal oraxillaryreg-ions within 2 or 3 weeks aftertheregression ofthe irradiated
tuniours. In some instances, new growth developed on the periphery of the
irradiated tumour, probably from tumour cells which bad not been included in the
exposed area. Thehistological appearance ofthese secondary tumours resembled
that of the primary, non-irradiated C3HB tumour.
Epilation and regrowth of gray hair appeared in the exposed areas 3 to 6
weeks after regression of the irradiated tumours. No ulceration of the skin in
the irradiated area was ever noted in the C3H mice once gray hair appeared.
AsignificantnumberofC3H mice hvedabout I yearafterregressionofthe tumours
and spontaneous tumours appeared in some of the C3H females. Upon micro-
scopic examination, these spontaneous tumours were found to be adenocarcino-
mata of the type usually occurring in mice ofthis C3H line.
B. Observation8on DBAHTransplantableMammary Titmour.
This tumour had been carried for 8generations ofserialtransplants in the DBA
mice from which it originated before it was used for irradiation. Although loo
per cent
" takes
" resulted in most instances, occasionany, however, an iniplant failed to produce a tumour in a DBA mouse which later proved to be resistant to
further viable tumourgrafts. According to Dr. Hauschka, this may be the result
of a mutant histocompatibility factor present in the DBA strain; in other words,
an outcome of genetic incompatibihty between the bost and the transplanted
tumour. To secure a better statistical evaluation of the results, a number of
mice were grafted with viable, non-irradiated DBAH tumour fragments to serve
as controls to those grafted with irradiated DBAH tumourimplants. The results
are recorded in Table IV. The first apparent effect of radiation on the tumour
implants occurred after a dose of 1500 r. Two out of 28 mice f'ailed to developRADIOSENSITIVITY AND
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TABLF, III.-Re&ults of X-Radiation of C3HB Tumours (1-0-1-5 cm. in diameter)
vivo.
Mice with
regressed
Dose (r.).
4000
Experiment Number of
No. mice.
1 . 12 males
tumour Remarks.
0 There was retardation of growth of the
tumours during the first week after
exposure; later the tumours increased
in size and grew steadily.
0 Six tumours decreased in size and nine
retained their size during the first
10 days after irradiation but later all
resumed their growth.
0 All treated tumours decreased in size
during the first week foRowing expo-
sure but later resumed their growth.
Sections of the tumours taken 22 days
after exposure showed active mitotic
figures. (Fig. 4.)
20-0 All 15 treated turnours decreased in size
considerably during 10-14 days after
irradiation. Three tumours regressed
within 5 weeks after exposure. The
skin healed and grey hair appeared on
the irradiated site. The mice lived in
apparent good health for 6-8 months.
Eleven tumours resumed growth and
grew steadily. Three tumours broke
through the skin and ulcerated. Histo-
logical sections showed mitotic activity
in mouse tumours.
48- 5 In 16 mice (10 males and 6 females) the
tumours regressed completely within
26 to 45 days after irradiation. The
treated mice lived without tumours
6-10 months. Two females developed
spontaneous tumours. Six tumours
decreasedconsiderably in size and later
started to growagainandgrewsteadily.
Eleven tumours decreased in size,
leaving only small, yeflowish nodes,
but secondary tumours developed
either in the inguinal or axiUary
regions. Microscopic sections of these
tumours resembled those of the non-
irradiated controls.
76-54 The tumours in 44 males and 18 females
regressed within 3 to 6 weeks after
radiation. These mice lived for 6 to
10 months. Six of the young females
produced litters. Four female mice
developed spontaneous tumours. The
tumours in the remaining 19 treated
mice decreased to small nodes, but
secondary tumours developed either in
the inguinal oraxillary regions.
100.0 Fifteen of the treated mice (14 males and
1 female) were free of tumours during
3 to 5 weeksfoUowingX-ray treatment.
Three (2 males and I female) of the
treated mice died within 19 days after
exposure ofthe tumours to X-radiation.
The tumours in these mice had de-
creased to tiny nodes. Microscopic
sections of these tumours showed only
disintegrated tumour tissue. The
males lived from 6 to II months after
regression of the tumours.
2 15
3 15
4 1-i
9 p 5000
pi- 6000
pt 7000
8000
males,
males)
10,000
iles,
Lales)
12,000
tles,
Lles)
5
6
7
33
(19 r
14 fe-r
81
(56 ma
25 fem
18
(16 ma
2 fema'.328 ANNA GOLDFEDER
tumours and tliev later proved to be
" immune
" to the RBAH tumour. The
delay in the latent period is probably a more rehable criterion than the tumour
" take
" for re-evaluation of the radiation effects in this case, because it could be
argued that the 2 mice in which the irradiated tumour- cells failed to produce
tumours possessed the mutant -histocompatibility factor. In one experinient,
a dose of4500 r resulted in 22-9 per cent of"takes", while a dose of4800 r resulted
in 13-0 per cent of
"takes
" and a dose of5000 r gaveonly 5-1 per cent of
" takes
However, in twoadditionalexperiments,afterdosesof5000 rand5200 r no "takes
ocetirred. The dose of 5000 r may, therefore, beregarded as the attenuating dose
for the DBAH tumour implants. The radiosensitivity of this tumour is graphi-
cally presented in Fig. 3.
TABLF, IV.-Re8ulm of Experiment8 with DBAH Tumour Implant8 Control and
X-Radiated in vitro.
Time of Number' Number Number of Number
Number tumour of mice of mice Takes of
of mice appearance with Takes without after re- resistant
Dose (r). grafted. (days). tumours. M tumours. implantation. mice.
Control 12 19,18 12 100-0 0 0 0
500 20 12-17 20 100-0 0 0
Control 10 14-16 9 90.0 I 0 1
1000 20 14-22 20 100-0 0 0
Control 20 12-17 20 100-0 0 0
1500 28 16-23 26 92-8 2 0 2
Control 25 14-18 24 96-0 1 0 1
2000 25 15-24 22 88-0 3 2 I
Control 2& 13-18 24 96-0 1 0 1
2500 25 16-25 21 84-0 4 4 0
Control 25, 12-18 25 100-0 0 0
3000 30 18-25 23 76-6 7 5 2
Control 25 14-16 24 96-0 1 0 1
3500 28 21-39 16 57-1 12 10 2
Control 20 14-18 20 100-0 0 0
4000 30 28-52 11 36-7 19 17 4)
Control 25 15-17 23 92-0 2 0 2
4500 35 33-82 8 22-9 27 25 2
Control 20 15-18 20 100-0 0 0
4800 30 46 4 13-0 26 23 3
Control 20 14-17 19 95-0 1 0 1
5000 35 38 2 5-1 33 29 4
.5000 25 0 0 25 24 1
Searchfor inditced re,8i8knce.
Analysis of the data recorded in Table IV reveals that 7 out of a total of 227
control mice (about 3 per cent) were found to be refractory. None of these 7
produced tumoursfoHowingimplantations ofviable tumourgrafts. In theexperi-
mental-mice, the number which failed to develop tumours was 150 out of a total
of 341 mice which had been implanted with irradiated tumour grafts. When
these mice were re-implanted with viable, non-irradiated tumour grafts, only 19
(about 6 per cent) remained resistant to re-inoculated DBAH tumour grafts.
This difference is not statistically significant because of the larger number of the
experimental mice.
The intradermal route was also used to test thepossibility ofinducing
" immu-
M'ty
" in the DBA mice. Fifteen males and 10 females about 3 nionths old were
injectedintradermally,using thetechniquepreviouslydescribed, with asuspensionRADIOSENSITIVITY AND
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ofthe DBAH tumour cells which had been irradiated with 5000 r. None ofthese
25 niiee developed tumours. Eighteen dayis later these -mice were reimplanted
subcutaneously with fiesh, viable tumour grafts. Palpable tumours, whicb,
grew progressively, appeared within 9 to 13 days in 14 out of the 15 reimplanted
male and in 9 out of 10 re-implanted female mice.
Two mice, one male and one female, in which the irradiated tumour cells
failed to produce tumours in the first place, remainedrefractory to twice repeated
implantations of viable tumour grafts. This result may also be ascribed to the
mutanthistocompatibihty factorpresent in these 2 mice.
Re8U1t8qfX-radiation o DBAH tumour8in vivo.
Table V records the observations made on a total of 227 mice (164 males and
63 females). As can benoted, doses of 4000 and 5000 rproduced, in no instances,
a total regression of a tumour. A significant number of tumours, however,
decreased to small firm nodules which, after 2 months or longer, resumed
growth. Aficroscopic sections taken from the regressing tumours showed an
increased prohferation of connective tissue (Fig. 5) when compared. with non-
irradiated DBAH tumours ofthe samegeneration oftransfer. This i's in contrast
to the C3HB tumour shown in Fig. 4. A rather sudden increase in the number
of tumours which showed regression was noted foRowing the application of doses
higher than 6000 r. Thus, 60 per cent of the tumours regressed after a dose of
7000 r. while a dose of 6000 r destroyed only 25 per cent of the treated tumours.
The larger percentage of the regressed tumours which had been treated with a
dose of 10,000 r indicates that this is the destructive dose for the DBAH trans-
plantable tiimours, ranging in size.from 1-0 to 1-5 cm. in cliameter. As in the case
of the C3HB tumour, this dose is twice as large as the dose necessary for the
attenuation ofgrafts ofthis tumour in vitro.
The majority of the mice.'m which tumours had regressed Eved in apparent
good health for I year or longer, and the young female' mice produced apparently normal litters. As in the C3H mice, spontaneous tumours appeared in the DBA
females after regression of the treated transplantable tumours, and gray hair
appeared on the site of exposure 2 to 3 weeks after the regression of the tumour
in the irradiated area. Only in two instances did ulceration of the skin occur.
In one instance the ulceration occurred 11 months and in the other 16 months
after disappearance, of the tumour. The ulceration-s persisted iintil the death of
the-ani'mals. These two instances may parallel radiation necrosis occasionally noted in human patients treated with X-rays. The mice which survived 181 2 months after regression of the tumours are shown in Fig. 6.
DISCITSSION.
Ever s'mce Ehrlich (1906) made his classical observatioD that an animal host
became resistant or
" inimune
" to re-implanted grafts of the same tumour after
a. tumourgraft failed to
" take", awidespreadinterest wasshown in the theoretical
and practical imphcations of this phenomenon. Many attempts were made to
induce immunity,to cancerous growths. Haaland (1909); Contamin (1910); Mottram and Russ (1917); Chambers, Scott and Russ, (1922); Clemmesen,
(1938) have sliow-n thiat a resistant state can be inducedbyimplanting the animals
with tuniour grafts previously attenuated with ionizing radiation. However, it330 ANNA GOLDFEDER
TA-BLE V.-ReSUltS of X-Radiation of DBAH Tumours, (1-0-1-5 cm. in diameter)
vivo.
Number of Number
experiment. of mice.
1 15 males
Cured mice
M Remarks.
0 Eight of the treated tumours decreased
in size after irradiation but resumed
their growth and grew steadily. The
turnours in the remaining 7 mice grew
steadily.
0 Fourteen tumours decreased considerably
in size within 10 days after irradiation
but later increased in size. Six
tumours grew steadily after exposure.
25 Five tumours regressed within 3 to 4
weeks following exposure. The cured
mice lived normally for 8-10 months
after treatment. Four treated tumours
shrank to small, firm nodes but meta-
static tumours developed in distant
regions. Eleven tumours continued to
grow after exposure. The firm regress-
ing tumours contained considerable
amounts of fibrous tissue.
60-0 Tumours in 6 females and in 9 males
regressed within 14-28 days after
irradiation. Seven ti-imoure decreased
in size but resumed their growth later.
Three mice died within 10 days after
treatment. The tumours in these mice
had decrea-sed in size. Microscopic
sections showed extensive necrosis in
the centre. but the edges contained
intact cells and mitoses. Two females
developed spontaneous tumours 6
months after regression of the treated
tumours.
7714 In 27 mice (20 males and 7 females) the
tumours regressed completely within
3 weeks after irradiation. The cured
mice lived normally thereafter, some
up to 1 year and longer. Four females
developed spontaneous tumours. In
the remaining 12 treated mice the
tumours decreased considerably in
size. In 5 ofthese the tumoursresumed
their growth and in 7 the tumours
decreased to small, firm nodes while
simultaneously metastatic tumours de-
veloped in distantregions. Microscopic
sections of the regressing tumours
consisted mainly of fibrous tissue.
85- 7 The tumours regressed completely in
30 treated mice (21 males and 9
females). Five fexnales developed
spontaneous tumours 6-7 months after
regression of the treated tumours.
The treated m1ce lived for as long as
I year and more after treatment. In
the remaining 5 mice, the tumours
decreased in size to small, firm nodules,
but metastatic ti-irnours developed in
regions distant from the exposed a-reas.
Microscopic sections of the regressing
tumour nodules consisted of necrotic
and fibrous tissue.
Dose (r).
4000
5000
6000
7000
2 20
(15 males,
5 females)
3 20
(16 males,
4 females)
4 25
(I7 males,
8 females)
5
6 35
(21 males,
14 females)
9000
35 8000RADIOSENSITIVITY AND
cc IMMUNIZING
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TABLEV--cont.
Number of Numbar Cured mice
experiinent. ofmice. Dose (r). (%) Remarks.
7 78 10,000 93- 6 In 57 males and 16 females the tumours
(59 males, regressed completely within 3-6 weeks.
19 females) One female mouse died 8 days after
irradiation of the tumour and another
female mouse developed a metastatic
tumour in the inguinal region. The
2remaining male micedeveloped meta-
static tumours on the edges of the
exposed areas. The young females
produced litters. Seven of the older
treated females developed spontaneous
tumours. The mice lived in apparent
good health up to 1 year and more.
Of aR treated mice only in two
-instances did ulceration of the skin in
the irradiated area occur 11 months
after regression of the tumour.
should be noted that in the experiments cited above, geneticaRy impure ammals
and tumoursgeneticaRy different from the hosts were used. The writer's interest
in the problem of induced resistance arose from investigations on mouse Sarcoma
180 grown in white mice of the Swiss strain (Golffeder, 1942). The mice were
made resistant to this tumour in almost 100 per cent ofthe casesfoRowingimplan-
tation with irradiated Sarcoma 180 grafts. The writer explored the possibihty ofinducing a resistant state in inbred animals by implanting into these animals
irradiated grafts of a tumour which originaRy developpd in an animal ofthe same
inbred line. These expenments were carried out hi an attempt to ascertain
whether ionizing radiation induces genetic and antigeriie changes in the tiimour
cells which make themforeign to the host. in whichtheyoriginated. Experiments
were also carried out on a reticulum cell lympbosarcoma, using Bagg's strain of
rats (Goldfeder, 1945b). According to the data given by the late Dr. Bagg, the
tumour had arisen in a rat of this particular line which had been inbred for 15
years. Ti.,mour grafts exposed to doses ranging froini 2200 to 2800 r failed to
grow after implantation into the normal rats. These rats later proved to be
resistant to re-inoculated viable tumour grafts. In the hght of the present experiments it appears that this was due to the fact that the rats ofthis line were
not entirely inbred. This is supported b' the observation made during the
experinients on the control, non-irradiated tumourgrafts : On occasions when the
non-irradiated tumour graft failed to
" tak'e," that rat became refractory to
re-implanted viable tumour grafts.
The failure to induce resistance in inbred strains ofrats totransplantable auto-
genbus tumours was brought forth in more recent experiments. Thus, grafts of
the mammar'y adenocarcinoma autogenous to the August inbred strain of rats,
as weH as grafts of the fibrosarcoma autogenous to the A-C rats atten'uated with
critical doses ofX-rays, failed to render the rats resistant to re-implanted viable
tumour grafts ofthe re-spective tumours (Goldfeder, 1953).
In the present experiments control, non-irradiated DBAH tumourgrafts failed
to grow in about 3 per cent of mice of the DBA strain in which the tumour
originated. These mice were found to be resistant to re-implantation of viable
grafts ofthe same tumour. .Among the DBA mice in which the irradiated DBAH
tumour grafts failed to take, 5-7 per cent proved to be resistant to re-inoculated,332 AN-NA GOLDFEDER
viable tumour grafts. This small difference in perceintaye is not statistically
significant because of the larger number of mice used for the experiments on
irradiatioin. These resistant DBA mice were taken to have a different genetic
constitution from that of the DBAH tumour. These observations, combined
with those made on inbred (homozygous) C3H mice and the autogenous mammary
adenocareinoma designated C3HB, brought forth the importance ofusing geneti-
cally pure and identical material (tumour and host) in this type ofexperiment in
order to secure reliable results. The failure to induce resistance in hostsbyirra-
diated autogenous tumour grafts emphasizes the strong genetic relationship bet-
ween the tumour cell and the host. The irradiation oftumour cells in the present
experiments did not make them foreign or antigenic to the host in which they
originaHy developed.
An analysis ofthe results recorded in Table I and in Table III reveals a differ-
encein theradiosensitivitybetween the C3HB and DBAH tumours. Forexample,
a dose of 3500 r gave 92 per cent
" takes
" of the C3HB tumour grafts and only
57
-1. per cent
" takes
" of the DBAH tumour grafts. At the borderhne of the
atteniiating dose, the difference in the radiosensitivity of these tumours is only
about 500 r. This range of attenuation dosage for both tumours is in line with
that.determined forimplants ofother mammary adenocarcinomas in inbred strains
of mice (Lawrence, Horn, Strong, 1937 ; Goldfeder, 1945a) and for a mammary
adenocarcinoma of an inbred line of rats (Eisen, 1940). On the other hand,
the C3HB mammary adenocarcinoma used in t-he present studies proved to be
more resistant to irradiation than the CM mammary adenocarcinoma used in
previousexperiments (Goldfeder, 1947), the latter requiring only 2700 r toprevent
itsgrafts from
"takes ". The difference in theradiosensitivity between the C3HB
and C3H mammary adenocarcinomas may be explained by (a) a difference in
degree of differentiation : the C3HB mammary adenocarcinoma in the present
experiments is a more anaplastic type of tumour consisting of Fiheets and bands
of closely packed cells, with relatively little fibrous connective tissue, while the
CM mammary adenocarcinoma previously reported (Goldfeder 1947) consisted
ofacini, uniformly distributed andseparatedby connective tissue; (b) by a differ-
ence in genetic make-up between the tumours and their hosts: the C3HB niam-
mary tumour was carried by serial transplants in pure inbred CM mice from
which it originated, while the mammary tumour, used in previous studies (1947-
.1950), was carried in C3H mice ofdifferent sublines and thus the tumoiir and the
hosts were not of the same genetic origin. Failure of the tumour to
" tak-e
"
in about 10 per cent ofthe hosts indicated that some ofthe CM mice used in the
experiments of 1947-1950 had a different genetic constitution than that of the
.mouse in which the tumour developed. The skewed curve illustrated in that
publication (Goldfeder, 1947) in contrast to the typical S-shaped curve obtained
in the present experiment may also be the result of the difference in the genetic make-up between the hosts and the tumour. The radiosensitivity of tumours
depends to alarge extent on whetherthey are growing in hosts of the same strain
from which they originated, or inforeign hosts as shown byAughterson, Tennant,
and Lawrence (1940). Irradiation of a transplantable mammary carcinoma in
Strain A mice in which the tumour originated induced regression only in I per
cent of the treated mice when 2500 r were apphed and in 48 per cent of mice
foRowing the application of 5000 r. When these doses were apphed to the same
tumour grown in hybrid mice, tumour regression was induced in 82 per centRADIOSENSITIVITY AND
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and 97' per cent of cases respectively. Thus tumours growing in animals of' a
strain in whichtheyoriginatedrequiredsignificantlylarger doses ofradiation than
those growing in foreign hosts. The antigenic reaction of' the foreign host is
thus a contributing f'actor in rendering the tumour more vulnerable to'regression
after irradiation.
The more anaplastic C3HB tumour proved to be more resistant to radiatioii
than the relatively more differentiated DBAH tumour. This corroborates the
observations made by the writer on another mouse mammary adenocarcinonia
(Goldfeder, 1950a) and those noted on human tumours. For example, Cathie
(1939), Lenz (1942) and Gliicksmann (1948) found that well differentiated cancers
regressed more readily and offered a better prognosis than the less differentiated
tumours.
The r'ole of connective tissue in the response of animal tumours to irradiation
and its relationship to the host was brought forth by Cramer (1932) aind byAugh-
terson, Tennant and Lawrence (1940). The relatively more pronounced proli-
feration of the connective tissue in the DBAH tiiniour than-in the C3HB tumour
may also be regarded as a contributing factor rendering the DBAH tumour more
vulnerable to irradiation. The observation of secondary tumours occurring in
the treated mice also seems to parallel observations made on human mammary
cancers. This observatioin indicates the failure of the disintegrated irradiated
tumour tissue to induce resistance in the hosts to new cancerous growths.
It has been noted that untreated metastatic tumours often regress after X-ravV
treatment of primary tumours (Sugiura, 1937; Aughterson, Tennant and Law-
rence, 1940). This observation has been attribiited to a supposed indirect effect
of irradiation (Sugiura, 1937). These observations could probably be explained
by the fact that the tumours were grown ingeneticallyforeign mice. The present
experiments on mice of geneticafly pure strains and their autogenous tumours
indicate that the indirect effect of irradiation is not sufficient to affect secondary
growths. Regressionofthesecondary tumours inX-raytreatedheterozygous mice
may be attributed to an antigenic effect' ehcited by the genetically differing
tumour tissue. The inability ofthe irradiated tumour tissue to induce
" immun-
ity
" in hosts from which it originated may indicate that no quahtative change of
a genetic or antigenic character occurred in the irradiated tumour cells which
would render them foreign to the hosts. Inbred hnes of mice and their tumours
offer far more suitable material for investigations of this type than heterozygous
mice. The observations made from such studies seem to paraRel those noted on
human mammary cancers.
In earlier publications (Goldfeder 1950b, 1952), the writer showed that a fast
growing, less differentiated mouse mammaryadenocarcinoma alsopossessed a more
vigorous metabolic rate and suggested that this propertv may have been one of
the factorsinfluencing theradiosensitivity ofthe mammary adenocarcinomas then
used. Whether this also holds true for the C3HB and DBAH mammary adeno-
carcinomas now described is as yet not known. Experiments on the metabolic
behavior ofthese tumours are in progress.
SUMMARY.
The radiosensitivity and ability to induce a resistant state i'n mi'ce of the same
strain were studied in twotransplantable nlammaryadenocarcinomata, designated334 ANNA GOLDFEDER
C3HB and DBAH, which had originated in mice ofthe respective inbred C3H and
DBA high cancer strains.
A difference in the radiosensitivity, both in vivo and in vitro, was observed
between C3HB and DBAH transplantable mammary tumours. A smaller irra-
diation dose was found to prevent the irradiated DBAH tumour grafts from
growing in vivo than was required to produce a similar effect on C3HB tumour
grafts. Similarly, for treatment of established tumours in vivo, the dose of irra-
diation which produced regression of the DBAH tumour was found to be smaller
than that which had a similar effect on the C3HB tumour. Some factors which
are involved in the difference in the radiosensitivity of these two tumours are the
state ofdifferentiation ofthe tumour cells and the amount ofstroma.
In both instances about half of the radiation dose, producing destruction of
the established tumours grown in their respective hosts, was required to obtain
the attenuation ofthe grafts ofboth C3HB and DBAH tumours.
The C3H mice in which the irradiated in vitro C3HB tumour grafts failed to
"take" or in which a well developed transplanted C3HB tumour regressed after
irradiation in vivo remained susceptible to reimplanted viable C3HB tumour
grafts. A small number of the DBA mice in which the viable DBAH tumour
grafts failed to "take "in vivo remained resistant to viable tumour grafts. Simil-
arly, a small number of the DBA mice in which the irradiated in vitro tumour
grafts failed to "take" was found resistant to re-implantation of fresh viable
tumour implants. This is explained by a difference between the genetic make-up
of some of the DBA mice and the DBAH tumour.
A significant number of mice of both strains lived in apparent good health
for 1 year and longer after regression of the in vivo irradiated tumours; among
these survivors the young females produced apparently normal litters. Spon-
taneous tumours also occurred among these female survivors on reaching cancer
age.
Thus, under the experimental conditions described, the question about the
possibility of inducing immunity in homozygous hosts to endogenous tumours
by irradiation of these tumours appears to have been answered in the negative..
The part played by the genetic relationship between the tumour and host in the
induction of resistance to the appearance of tumours was brought forth. The
importance is stressed of using tumour material genetically identical with the
host in irradiation experiments.
My sincere thanks are due to Dr. J. J. Bittner for the C3H high cancer line
mice and to Dr. T.C. Hauschka for mice of the DBA high cancer line which they
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Carl B. Braestrup, Senior Physicist of the Department of Hospitals, New York
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